Back to search
FDAFDA · Food and drugs·Recall number Z-1803-2013

BBL Brucella Laked Blood Agar with Kanamycin and Vancomycin (KV), Catalog # 297840, packaged in cartons of 20 plates, labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Brucella Laked Blood with KV is used for the selective isolation of fastidious and slow growing, obligately anaerobic bacteria from the same specimen.

Published July 31, 2013 · Recall initiated: June 6, 2013

Summary

FDA records medical device Class II recall Z-1803-2013, published July 31, 2013 and initiated June 6, 2013. Recalling firm: Becton Dickinson & Co.; Status: Terminated; Reported quantity: 92 cartons; Lot: Lot 3078280 Exp 6/27/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbiological identification media may exhibit reduced levels of Vancomycin.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Co.
Distributor
Worldwide distribution: US (nationwide) and countries of:Belgium, Canada, Columbia, Mexico, Singapore, and Taiwan.
Lot
Lot 3078280 Exp 6/27/13
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BBL Brucella Laked Blood Agar with Kanamycin and Vancomycin (KV), Catalog # 297840, packaged in cartons of 20 plates, labeled in part ***Becton, Dickinson and Company 7 Loveton Circle Sparks, MD 21152 USA 800-638-8663 www.bd.com/ds*** Brucella Laked Blood with KV is used for the selective isolation of fastidious and slow growing, obligately anaerobic bacteria from the same specimen. recalled?

Yes. FDA published recall Z-1803-2013 on July 31, 2013. Reported hazard: Microbiological identification media may exhibit reduced levels of Vancomycin.

What should I do if I have this product?

Voluntary: Firm initiated · Letter